rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Sep' 20 Jun' 20 Mar' 20 Dec' 19 Sep' 19
Sales 137.55 155.96 113.64 116.88 100.72
Operating profit 23.05 29.00 18.39 20.26 12.79
Interest 1.32 0.79 1.67 1.26 2.47
Gross profit 34.68 28.26 16.63 19.00 18.19
EPS (Rs) 0.57 0.54 0.18 0.32 0.29
Quarterly  results in details
Sep' 20 Jun' 20 Mar' 20 Dec' 19 Sep' 19
Other income 12.96 0.05 -0.08 0.01 7.87
Stock adjustment -0.36 0.43 -8.21 2.47 -1.95
Raw material 70.95 66.34 57.41 51.82 53.86
Power and fuel - - - - -
Employee expenses 12.86 12.27 12.34 12.44 11.90
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 31.05 47.91 33.70 29.88 24.12
Provisions made - - - - -
Depreciation 3.67 3.34 3.46 2.88 2.66
Taxation 7.48 2.87 5.76 3.15 3.66
Net profit / loss 23.53 22.06 7.41 12.98 11.86
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 40.93 40.93 40.93 40.93 40.93
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 16.76 18.60 16.18 17.33 12.70
GPM (%) 23.04 18.12 14.65 16.26 16.75
NPM (%) 15.64 14.14 6.53 11.10 10.93

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close